ConductScience.org, home

Paper17530362

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.

Yoneda M and 16 others. J Gastroenterol, 2007. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. Papers, record 17530362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17530362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
PubMed
Journal
J Gastroenterol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2018-11-13
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yoneda MMasato
2Mawatari HHironori
3Fujita KKoji
4Yonemitsu KKyoko
5Kato SShingo
6Takahashi HHirokazu
7Kirikoshi HHiroyuki
8Inamori MMasahiko
9Nozaki YYuichi
10Abe YYasunobu
11Kubota KKensuke
12Saito SSatoru
13Iwasaki TTomoyuki
14Terauchi YYasuo
15Togo SShinji
16Maeyama SShiro
17Nakajima AAtsushi

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Collagen Type IVMajor topic
Fatty LiverMajor topic
Adult
Disease Progression
Female
Fibrosis
Humans
Hyaluronic Acid
Insulin Resistance
Liver
Logistic Models
Male
Middle Aged
Multivariate Analysis
ROC Curve

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115605303Clinical aspects of fatty liver disease.Semin Liver Dis2004https://conductscience.org/library/papers/15605303PubMed
212542595Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?J Gastroenterol Hepatol2003https://conductscience.org/library/papers/12542595PubMed
37489979The natural history of nonalcoholic fatty liver: a follow-up study.Hepatology1995https://conductscience.org/library/papers/7489979PubMed
412883486Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.Hepatology2003https://conductscience.org/library/papers/12883486PubMed
510833486Liver fibrosis in overweight patients.Gastroenterology2000https://conductscience.org/library/papers/10833486PubMed
610888734Appropriateness of liver biopsy.Can J Gastroenterol2000https://conductscience.org/library/papers/10888734PubMed
710573511Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.Hepatology1999https://conductscience.org/library/papers/10573511PubMed
89839117Correct homeostasis model assessment (HOMA) evaluation uses the computer program.Diabetes Care1998https://conductscience.org/library/papers/9839117PubMed
911522755Nonalcoholic steatohepatitis.Gastroenterology2001https://conductscience.org/library/papers/11522755PubMed
101631498
Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen.
Scand J Gastroenterol1992https://conductscience.org/library/papers/1631498PubMed
1111961152Nonalcoholic fatty liver disease.N Engl J Med2002https://conductscience.org/library/papers/11961152PubMed
121455153Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.Scand J Clin Lab Invest1992https://conductscience.org/library/papers/1455153PubMed
1315633226Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.World J Gastroenterol2005https://conductscience.org/library/papers/15633226PubMed
1412404245AGA technical review on nonalcoholic fatty liver disease.Gastroenterology2002https://conductscience.org/library/papers/12404245PubMed
1512434092[Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].Gastroenterol Clin Biol2002https://conductscience.org/library/papers/12434092PubMed
167382552Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.Mayo Clin Proc1980https://conductscience.org/library/papers/7382552PubMed
1712883497A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Hepatology2003https://conductscience.org/library/papers/12883497PubMed
1812472968Treatment of non-alcoholic fatty liver disease.J Gastroenterol Hepatol2002https://conductscience.org/library/papers/12472968PubMed
193410220Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.Gastroenterology1988https://conductscience.org/library/papers/3410220PubMed
2010348825Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.Gastroenterology1999https://conductscience.org/library/papers/10348825PubMed

See all 31 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42952688Analysis of pathogenesis-related factors of Streptococcus mutans from the oral cavity of patients with nonalcoholic steatohepatitis.Front Immunol2026https://conductscience.org/library/papers/42952688PubMed
42315674CLEIA-based type IV collagen 7S for second-step assessment of MRE-defined clinically significant fibrosis in MASLD with indeterminate FIB-4.Sci Rep2026https://conductscience.org/library/papers/42315674PubMed
40832563Echocardiographic measurement of inferior vena cava diameter for estimating central venous pressure in adult Fontan patients.Eur Heart J Imaging Methods Pract2025https://conductscience.org/library/papers/40832563PubMed
39055237Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis-3 index.JGH Open2024https://conductscience.org/library/papers/39055237PubMed
39035406Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.Pediatr Gastroenterol Hepatol Nutr2024https://conductscience.org/library/papers/39035406PubMed
37842727Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.Gut Liver2024https://conductscience.org/library/papers/37842727PubMed
36326882Liver stiffness assessed by magnetic resonance elastography predicts clinical outcomes in patients with heart failure and without chronic liver disease.Eur Radiol2023https://conductscience.org/library/papers/36326882PubMed
36307441A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs.Sci Rep2022https://conductscience.org/library/papers/36307441PubMed
35822119Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study.JGH Open2022https://conductscience.org/library/papers/35822119PubMed
35352460Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease.Hepatol Res2022https://conductscience.org/library/papers/35352460PubMed
35204498Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.Diagnostics (Basel)2022https://conductscience.org/library/papers/35204498PubMed
34131471Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease.World J Hepatol2021https://conductscience.org/library/papers/34131471PubMed
34105780Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis.Hepatology2021https://conductscience.org/library/papers/34105780PubMed
34064337Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity.J Clin Med2021https://conductscience.org/library/papers/34064337PubMed
33857552Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis.Adv Drug Deliv Rev2021https://conductscience.org/library/papers/33857552PubMed
33829335Predictive scoring system for advanced liver fibrosis in Japanese patients with severe obesity.Surg Today2021https://conductscience.org/library/papers/33829335PubMed
32570776Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan.Int J Mol Sci2020https://conductscience.org/library/papers/32570776PubMed
32329963Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study.J Diabetes Investig2020https://conductscience.org/library/papers/32329963PubMed
31933238Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.Pharmaceut Med2019https://conductscience.org/library/papers/31933238PubMed
31721770Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.PLoS One2019https://conductscience.org/library/papers/31721770PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17530362

GET https://conductscience.org/api/papers/v1/17530362/references?page=2